Differences	O
in	O
depression	B:C0344315
,	O
treatment	O
satisfaction	O
and	O
injection	O
behavior	I:C0556406
in	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

Differences	O
in	O
depression	O
,	O
treatment	O
satisfaction	O
and	O
injection	B:C0556406
behavior	I:C0556406
in	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

Differences	O
in	O
depression	O
,	O
treatment	O
satisfaction	O
and	O
injection	O
behavior	I:C0556406
in	O
adults	O
with	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

Differences	O
in	O
depression	O
,	O
treatment	O
satisfaction	O
and	O
injection	O
behavior	I:C0556406
in	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	B:C1262113
.	O

To	O
assess	O
the	O
prevalence	O
of	O
lipohypertrophy	B:C1262113
,	O
and	O
to	O
compare	O
differences	O
in	O
external	O
,	O
personal	O
,	O
and	O
regimen	O
factors	O
in	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

To	O
assess	O
the	O
prevalence	O
of	O
lipohypertrophy	O
,	O
and	O
to	O
compare	O
differences	O
in	O
external	O
,	O
personal	O
,	O
and	O
regimen	B:C0040808
factors	O
in	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

To	O
assess	O
the	O
prevalence	O
of	O
lipohypertrophy	O
,	O
and	O
to	O
compare	O
differences	O
in	O
external	O
,	O
personal	O
,	O
and	O
regimen	O
factors	O
in	O
adults	O
with	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

To	O
assess	O
the	O
prevalence	O
of	O
lipohypertrophy	O
,	O
and	O
to	O
compare	O
differences	O
in	O
external	O
,	O
personal	O
,	O
and	O
regimen	O
factors	O
in	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	B:C1262113
.	O

Suboptimal	O
insulin	B:C0021641
injection	O
behavior	I:C0556406
is	O
associated	O
with	O
lipohypertrophy	O
,	O
which	O
may	O
affect	O
insulin	O
absorption	O
and	O
lead	O
to	O
blood	O
glucose	I:C0005802
fluctuations	O
.	O

Suboptimal	O
insulin	O
injection	B:C0556406
behavior	I:C0556406
is	O
associated	O
with	O
lipohypertrophy	O
,	O
which	O
may	O
affect	O
insulin	O
absorption	O
and	O
lead	O
to	O
blood	O
glucose	I:C0005802
fluctuations	O
.	O

Suboptimal	O
insulin	O
injection	O
behavior	I:C0556406
is	O
associated	O
with	O
lipohypertrophy	B:C1262113
,	O
which	O
may	O
affect	O
insulin	O
absorption	O
and	O
lead	O
to	O
blood	O
glucose	I:C0005802
fluctuations	O
.	O

Suboptimal	O
insulin	O
injection	O
behavior	I:C0556406
is	O
associated	O
with	O
lipohypertrophy	O
,	O
which	O
may	O
affect	O
insulin	B:C0021641
absorption	O
and	O
lead	O
to	O
blood	O
glucose	I:C0005802
fluctuations	O
.	O

Suboptimal	O
insulin	O
injection	O
behavior	I:C0556406
is	O
associated	O
with	O
lipohypertrophy	O
,	O
which	O
may	O
affect	O
insulin	O
absorption	O
and	O
lead	O
to	O
blood	B:C0005802
glucose	I:C0005802
fluctuations	O
.	O

Suboptimal	O
insulin	O
injection	O
behavior	I:C0556406
is	O
associated	O
with	O
lipohypertrophy	O
,	O
which	O
may	O
affect	O
insulin	O
absorption	O
and	O
lead	O
to	O
blood	O
glucose	I:C0005802
fluctuations	B:C0231239
.	O

Few	O
,	O
if	O
any	O
studies	B:C0008972
have	O
investigated	O
how	O
external	O
,	O
personal	O
,	O
and	O
regimen	O
factors	O
differ	O
in	O
people	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

Few	O
,	O
if	O
any	O
studies	O
have	O
investigated	O
how	O
external	O
,	O
personal	O
,	O
and	O
regimen	B:C0040808
factors	O
differ	O
in	O
people	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

Few	O
,	O
if	O
any	O
studies	O
have	O
investigated	O
how	O
external	O
,	O
personal	O
,	O
and	O
regimen	O
factors	O
differ	O
in	O
people	B:C0027361
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

Few	O
,	O
if	O
any	O
studies	O
have	O
investigated	O
how	O
external	O
,	O
personal	O
,	O
and	O
regimen	O
factors	O
differ	O
in	O
people	O
with	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	O
.	O

Few	O
,	O
if	O
any	O
studies	O
have	O
investigated	O
how	O
external	O
,	O
personal	O
,	O
and	O
regimen	O
factors	O
differ	O
in	O
people	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
and	O
different	O
degrees	O
of	O
lipohypertrophy	B:C1262113
.	O

A	O
cross-sectional	B:C0010362
study	I:C0010362
including	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
at	O
a	O
diabetes	O
outpatient	O
clinic	O
in	O
a	O
Norwegian	O
university	I:C0020028
hospital	I:C0020028
.	O

A	O
cross-sectional	O
study	I:C0010362
including	O
adults	O
with	O
type	B:C0011854
1	I:C0011854
diabetes	I:C0011854
at	O
a	O
diabetes	O
outpatient	O
clinic	O
in	O
a	O
Norwegian	O
university	I:C0020028
hospital	I:C0020028
.	O

A	O
cross-sectional	O
study	I:C0010362
including	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
at	O
a	O
diabetes	O
outpatient	O
clinic	B:C0442592
in	O
a	O
Norwegian	O
university	I:C0020028
hospital	I:C0020028
.	O

A	O
cross-sectional	O
study	I:C0010362
including	O
adults	O
with	O
type	O
1	I:C0011854
diabetes	I:C0011854
at	O
a	O
diabetes	O
outpatient	O
clinic	O
in	O
a	O
Norwegian	B:C0020028
university	I:C0020028
hospital	I:C0020028
.	O

Participants	B:C0679646
(	O
n=215	O
)	O
were	O
included	O
consecutively	O
at	O
scheduled	O
appointments	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	B:C0011847
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	B:C0021641
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	B:C0087111
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	B:C0034394
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	B:C3853034
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	B:C4075707
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	B:C0344315
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	B:C2706101
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	B:C0231303
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	B:C0282574
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	B:C3658239
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	B:C0282574
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	B:C0451116
)	O
,	O
and	O
motivation	O
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	B:C0026605
(	O
TSRQ	O
)	O
,	O
were	O
collected	O
.	O

Sociodemographic	O
-	O
,	O
diabetes	O
-	O
and	O
insulin	O
treatment	O
data	O
,	O
and	O
self	O
-	I:C0034394
report	I:C0034394
questionnaires	I:C0034394
concerning	O
patient	O
activation	I:C3853034
(	O
PAM	O
)	O
,	O
depression	O
(	O
PHQ	O
-	I:C2706101
2	I:C2706101
)	O
,	O
diabetes	O
distress	I:C0231303
(	O
diabetes	O
distress	I:C0282574
)	O
,	O
type	O
D	I:C3658239
personality	I:C3658239
(	O
DS14	O
)	O
,	O
treatment	O
satisfaction	O
(	O
ITSQ	O
)	O
,	O
and	O
motivation	O
(	O
TSRQ	B:C0282574
)	O
,	O
were	O
collected	O
.	O

Lipohypertrophic	B:C1262113
injection	O
sites	O
were	O
identified	O
by	O
palpation	O
by	O
diabetes	O
specialist	I:C0028661
nurses	I:C0028661
.	O

Lipohypertrophic	O
injection	O
sites	O
were	O
identified	O
by	O
palpation	B:C0030247
by	O
diabetes	O
specialist	I:C0028661
nurses	I:C0028661
.	O

Lipohypertrophic	O
injection	O
sites	O
were	O
identified	O
by	O
palpation	O
by	O
diabetes	B:C0028661
specialist	I:C0028661
nurses	I:C0028661
.	O

Lipohypertrophy	B:C1262113
was	O
present	O
in	O
53	O
%	O
and	O
was	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	O
(	O
63	O
%	O
)	O
compared	O
to	O
insulin	O
pump	I:C1140609
users	O
(	O
34	O
%	O
)	O
.	O

Lipohypertrophy	O
was	O
present	B:C0150312
in	O
53	O
%	O
and	O
was	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	O
(	O
63	O
%	O
)	O
compared	O
to	O
insulin	O
pump	I:C1140609
users	O
(	O
34	O
%	O
)	O
.	O

Lipohypertrophy	O
was	O
present	O
in	O
53	O
%	O
and	O
was	O
more	O
frequent	O
in	O
insulin	B:C0181364
pen	I:C0181364
users	O
(	O
63	O
%	O
)	O
compared	O
to	O
insulin	O
pump	I:C1140609
users	O
(	O
34	O
%	O
)	O
.	O

Lipohypertrophy	O
was	O
present	O
in	O
53	O
%	O
and	O
was	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	B:C1706077
(	O
63	O
%	O
)	O
compared	O
to	O
insulin	O
pump	I:C1140609
users	O
(	O
34	O
%	O
)	O
.	O

Lipohypertrophy	O
was	O
present	O
in	O
53	O
%	O
and	O
was	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	O
(	O
63	O
%	O
)	O
compared	O
to	O
insulin	B:C1140609
pump	I:C1140609
users	O
(	O
34	O
%	O
)	O
.	O

Lipohypertrophy	O
was	O
present	O
in	O
53	O
%	O
and	O
was	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	O
(	O
63	O
%	O
)	O
compared	O
to	O
insulin	O
pump	I:C1140609
users	B:C1706077
(	O
34	O
%	O
)	O
.	O

Participants	B:C0679646
with	O
two	O
or	O
more	O
lipohypertrophic	O
areas	O
had	O
higher	O
depression	O
scores	O
,	O
lower	O
treatment	O
satisfaction	O
with	O
glycemic	O
control	I:C0342299
,	O
higher	O
bolus	O
doses	I:C1511237
,	O
and	O
reported	O
suboptimal	O
injection	O
behavior	I:C0556406
compared	O
to	O
those	O
with	O
no	O
lipohypertrophic	O
areas	I:C1262113
.	O

Participants	O
with	O
two	O
or	O
more	O
lipohypertrophic	B:C1262113
areas	O
had	O
higher	O
depression	O
scores	O
,	O
lower	O
treatment	O
satisfaction	O
with	O
glycemic	O
control	I:C0342299
,	O
higher	O
bolus	O
doses	I:C1511237
,	O
and	O
reported	O
suboptimal	O
injection	O
behavior	I:C0556406
compared	O
to	O
those	O
with	O
no	O
lipohypertrophic	O
areas	I:C1262113
.	O

Participants	O
with	O
two	O
or	O
more	O
lipohypertrophic	O
areas	O
had	O
higher	O
depression	O
scores	O
,	O
lower	O
treatment	O
satisfaction	O
with	O
glycemic	B:C0342299
control	I:C0342299
,	O
higher	O
bolus	O
doses	I:C1511237
,	O
and	O
reported	O
suboptimal	O
injection	O
behavior	I:C0556406
compared	O
to	O
those	O
with	O
no	O
lipohypertrophic	O
areas	I:C1262113
.	O

Participants	O
with	O
two	O
or	O
more	O
lipohypertrophic	O
areas	O
had	O
higher	O
depression	O
scores	O
,	O
lower	O
treatment	O
satisfaction	O
with	O
glycemic	O
control	I:C0342299
,	O
higher	O
bolus	B:C1511237
doses	I:C1511237
,	O
and	O
reported	O
suboptimal	O
injection	O
behavior	I:C0556406
compared	O
to	O
those	O
with	O
no	O
lipohypertrophic	O
areas	I:C1262113
.	O

Participants	O
with	O
two	O
or	O
more	O
lipohypertrophic	O
areas	O
had	O
higher	O
depression	O
scores	O
,	O
lower	O
treatment	O
satisfaction	O
with	O
glycemic	O
control	I:C0342299
,	O
higher	O
bolus	O
doses	I:C1511237
,	O
and	O
reported	O
suboptimal	O
injection	B:C0556406
behavior	I:C0556406
compared	O
to	O
those	O
with	O
no	O
lipohypertrophic	O
areas	I:C1262113
.	O

Participants	O
with	O
two	O
or	O
more	O
lipohypertrophic	O
areas	O
had	O
higher	O
depression	O
scores	O
,	O
lower	O
treatment	O
satisfaction	O
with	O
glycemic	O
control	I:C0342299
,	O
higher	O
bolus	O
doses	I:C1511237
,	O
and	O
reported	O
suboptimal	O
injection	O
behavior	I:C0556406
compared	O
to	O
those	O
with	O
no	O
lipohypertrophic	B:C1262113
areas	I:C1262113
.	O

There	O
were	O
no	O
differences	O
in	O
patient	B:C3853034
activation	I:C3853034
,	O
diabetes	O
distress	I:C0231303
,	O
type	O
D	I:C3658239
personality	I:C3658239
,	O
or	O
motivation	O
between	O
the	O
groups	O
.	O

There	O
were	O
no	O
differences	O
in	O
patient	O
activation	I:C3853034
,	O
diabetes	B:C0231303
distress	I:C0231303
,	O
type	O
D	I:C3658239
personality	I:C3658239
,	O
or	O
motivation	O
between	O
the	O
groups	O
.	O

There	O
were	O
no	O
differences	O
in	O
patient	O
activation	I:C3853034
,	O
diabetes	O
distress	I:C0231303
,	O
type	B:C3658239
D	I:C3658239
personality	I:C3658239
,	O
or	O
motivation	O
between	O
the	O
groups	O
.	O

There	O
were	O
no	O
differences	O
in	O
patient	O
activation	I:C3853034
,	O
diabetes	O
distress	I:C0231303
,	O
type	O
D	I:C3658239
personality	I:C3658239
,	O
or	O
motivation	B:C0026605
between	O
the	O
groups	O
.	O

Compared	O
to	O
pump	B:C1140609
treatment	O
,	O
pen	O
treatment	O
requires	O
greater	O
awareness	O
of	O
injection	O
technique	O
.	O

Compared	O
to	O
pump	O
treatment	B:C0087111
,	O
pen	O
treatment	O
requires	O
greater	O
awareness	O
of	O
injection	O
technique	O
.	O

Compared	O
to	O
pump	O
treatment	O
,	O
pen	B:C0181364
treatment	O
requires	O
greater	O
awareness	O
of	O
injection	O
technique	O
.	O

Compared	O
to	O
pump	O
treatment	O
,	O
pen	O
treatment	B:C0087111
requires	O
greater	O
awareness	O
of	O
injection	O
technique	O
.	O

Compared	O
to	O
pump	O
treatment	O
,	O
pen	O
treatment	O
requires	O
greater	O
awareness	B:C0004448
of	O
injection	O
technique	O
.	O

Depressive	B:C0086132
symptoms	I:C0086132
and	O
lower	O
treatment	O
satisfaction	O
might	O
affect	O
diabetes	O
self	O
-	I:C0086969
management	I:C0086969
and	O
glycemic	O
control	I:C0342299
,	O
but	O
the	O
association	O
with	O
lipohypertrophy	O
needs	O
further	O
exploration	O
.	O

Depressive	O
symptoms	I:C0086132
and	O
lower	O
treatment	O
satisfaction	O
might	O
affect	O
diabetes	B:C0011847
self	O
-	I:C0086969
management	I:C0086969
and	O
glycemic	O
control	I:C0342299
,	O
but	O
the	O
association	O
with	O
lipohypertrophy	O
needs	O
further	O
exploration	O
.	O

Depressive	O
symptoms	I:C0086132
and	O
lower	O
treatment	O
satisfaction	O
might	O
affect	O
diabetes	O
self	B:C0086969
-	I:C0086969
management	I:C0086969
and	O
glycemic	O
control	I:C0342299
,	O
but	O
the	O
association	O
with	O
lipohypertrophy	O
needs	O
further	O
exploration	O
.	O

Depressive	O
symptoms	I:C0086132
and	O
lower	O
treatment	O
satisfaction	O
might	O
affect	O
diabetes	O
self	O
-	I:C0086969
management	I:C0086969
and	O
glycemic	B:C0342299
control	I:C0342299
,	O
but	O
the	O
association	O
with	O
lipohypertrophy	O
needs	O
further	O
exploration	O
.	O

Depressive	O
symptoms	I:C0086132
and	O
lower	O
treatment	O
satisfaction	O
might	O
affect	O
diabetes	O
self	O
-	I:C0086969
management	I:C0086969
and	O
glycemic	O
control	I:C0342299
,	O
but	O
the	O
association	O
with	O
lipohypertrophy	B:C1262113
needs	O
further	O
exploration	O
.	O

Lipohypertrophy	B:C1262113
is	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	O
compared	O
to	O
pump	O
users	O
.	O

Lipohypertrophy	O
is	O
more	O
frequent	O
in	O
insulin	B:C0181364
pen	I:C0181364
users	O
compared	O
to	O
pump	O
users	O
.	O

Lipohypertrophy	O
is	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	B:C1706077
compared	O
to	O
pump	O
users	O
.	O

Lipohypertrophy	O
is	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	O
compared	O
to	O
pump	B:C1140609
users	O
.	O

Lipohypertrophy	O
is	O
more	O
frequent	O
in	O
insulin	O
pen	I:C0181364
users	O
compared	O
to	O
pump	O
users	B:C1706077
.	O

Nurses	B:C0028661
should	O
focus	O
on	O
injection	O
technique	O
education	O
,	O
and	O
should	O
also	O
screen	O
for	O
depressive	O
symptoms	I:C0086132
and	O
treatment	O
satisfaction	O
as	O
those	O
factors	O
could	O
be	O
associated	O
with	O
development	O
of	O
lipohypertrophy	O
.	O

Nurses	O
should	O
focus	O
on	O
injection	O
technique	O
education	O
,	O
and	O
should	O
also	O
screen	B:C0220908
for	O
depressive	O
symptoms	I:C0086132
and	O
treatment	O
satisfaction	O
as	O
those	O
factors	O
could	O
be	O
associated	O
with	O
development	O
of	O
lipohypertrophy	O
.	O

Nurses	O
should	O
focus	O
on	O
injection	O
technique	O
education	O
,	O
and	O
should	O
also	O
screen	O
for	O
depressive	B:C0086132
symptoms	I:C0086132
and	O
treatment	O
satisfaction	O
as	O
those	O
factors	O
could	O
be	O
associated	O
with	O
development	O
of	O
lipohypertrophy	O
.	O

Nurses	O
should	O
focus	O
on	O
injection	O
technique	O
education	O
,	O
and	O
should	O
also	O
screen	O
for	O
depressive	O
symptoms	I:C0086132
and	O
treatment	O
satisfaction	O
as	O
those	O
factors	O
could	O
be	O
associated	O
with	O
development	O
of	O
lipohypertrophy	B:C1262113
.	O

